Segment, Customer and Geographic Information

12 Months Ended

Dec. 31, 2022

Segment Reporting [Abstract]

Segment, Customer and Geographic Information

Note 14. Segment, Customer and Geographic Information

The Company continues to operate in only one segment, blood safety. The Company’s chief executive officer is the chief operating decision maker who evaluates performance based on the net revenues and operating loss of the blood safety segment. The Company considers the sale of all of its INTERCEPT Blood System products to be similar in nature and function, and any revenue earned from services is minimal.

The Company’s operations outside of the U.S. include a wholly-owned subsidiary headquartered in Europe. The Company’s operations in the U.S. are responsible for the R&D and global and domestic commercialization of the INTERCEPT Blood System, while operations in Europe are responsible for the commercialization efforts of the platelet and plasma systems in Europe, the Commonwealth of Independent States and the Middle East. Product revenues are attributed to each region based on the location of the customer, and in the case of non-product revenues, on the location of the collaboration partner.

The Company had the following significant customers that accounted for more than 10% of the Company’s total product revenue, during the years ended December 31, 2022, 2021 and 2020 (in percentages):

	Year Ended December 31,
	2022	2021	2020
American Red Cross	35%	30%	20%
Établissement Français du Sang	12%	16%	21%

Revenues by geographical location were based on the location of the customer during the years ended December 31, 2022, 2021 and 2020, and was as follows (in thousands):

	Year Ended December 31,
	2022		2021		2020
Product revenue:
United States	$	101,391	$	67,498	$	31,517
France		19,327		20,887		19,404
Other countries		41,330		42,474		40,999
Total product revenue		162,048		130,859		91,920
Government contract revenue:
United States		26,267		28,659		22,329
Total government contract revenue		26,267		28,659		22,329
Total revenue	$	188,315	$	159,518	$	114,249

Long-lived assets by geographical location at December 31, 2022 and December 31, 2021, were as follows (in thousands):

	December 31,
	2022		2021
U.S. and territories	$	10,705	$	11,931
Europe & other		264		277
Total long-lived assets	$	10,969	$	12,208